Why West Pharmaceutical Services (WST) Stock Is Nosediving

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the company reported disappointing fourth-quarter 2024 results: its full-year revenue and earnings guidance fell short of Wall Street’s estimates.

West Pharmaceutical falls -31.7%

West Pharmaceutical (WST) is down -31.7%, or -$102.06 to $220.22.Maximize Your Portfolio with Data Driven Insights:Leverage the power of